Cart
sales@molnova.com
6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethenyl]chromone
CAS No. ———
6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethenyl]chromone( ——— )
Catalog No. M39077 CAS No. ———
6,7-dimethoxy-2-[2-(4'-hydroxyphenyl)ethenyl]chromone
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name6,7-dimethoxy-2-[2-(4-hydroxyphenyl)ethenyl]chromone
-
NoteResearch use only, not for human use.
-
Brief Description6,7-dimethoxy-2-[2-(4'-hydroxyphenyl)ethenyl]chromone
-
Description6,7-dimethoxy-2-[2-(4'-hydroxyphenyl)ethenyl]chromone
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SDZ285-428
NVP-VID-400 (SDZ285-428) is a CYP24A1 inhibitor.
-
KRA-533
KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.
-
RET-IN-1
RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 552.
